← SynDRA
BRD-K93725829
SynDRA canonical compound SYN0062536 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | MAPK1 |
| Mechanism of action | MAP kinase inhibitor |
Cross-references
Synonyms
- ERK-inhibitor-11E
- RefChem:912040
- VX-11e
- VTX-11e
- VX11E
- NCGC00242487
- C24H20Cl2FN5O2
- Vertex-11e
- pyrimidylpyrrole, 11e
- ERK11e
- ERK-11e
- GTPL9375
- orb1304470
- SCHEMBL15859235
- SCHEMBL29351720
- VX-11e(TCS ERK 11e)
- BDBM35657
- CHEBI:95049
- GLXC-05348
- VX-11e(TCS ERK 11e)?
- EX-A1570
- s7709
- AKOS024458172
- CCG-269689
- CS-0995
- NCGC00242487-01
- NCGC00242487-02
- NCGC00242487-06
- NCGC00242487-09
- AC-29012
- AS-16952
- HY-14178
- V9201
- C77026
- F863781
- BRD-K93725829-001-01-2
- BRD-K93725829-001-03-8
- 4-[2-(2-chloro-4-fluoroanilino)-5-methyl-4-pyrimidinyl]-N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-1H-pyrrole-2-carboxamide
- 4-[2-[(2-Chloro-4-fluorophenyl)amino]-5-methyl-4-pyrimidinyl]-N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-1H-pyrrole-2-carboxamide
Look up BRD-K93725829 in the interactive SynDRA portal →